NCT02390635 2026-04-17
PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia
M.D. Anderson Cancer Center
Phase 1 Recruiting
Clinical Trials
7 trialsNCT01409161 2025-12-17
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT02938858 2025-12-11
French Registry of First-line Treatment of Acute Promyelocytic Leukemia
Groupe Francophone des Myelodysplasies
Active not recruiting
NCT07203885 2025-10-31
LEAP
Harvard Medical School (HMS and HSDM)
Phase NA Completed
NCT07187505 2025-09-23
Venetoclax Combined With ATRA and ATO in Hyperleukocytic Acute Promyelocytic Leukemia
Anhui Medical University
Phase NA Active not recruiting
NCT04687176 2025-06-12
Frontline Oral Arsenic Trioxide for APL
The University of Hong Kong
Phase 2 Recruiting
NCT06982274 2025-05-30
IC-APL2020
Instituto do Cancer do Estado de São Paulo
Phase 2 Recruiting